Encephalitis, Tick-Borne: Clinical Trials

2 trials for Encephalitis, Tick-Borne, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 not yet recruiting. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Not yet recruiting 1

Follow Encephalitis, Tick-Borne: new trials by email Literature Review of Encephalitis, Tick-Borne trials Research Report on Encephalitis, Tick-Borne

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.
Human monoclonal antibody TBE025, intravenous infusion - The Tick-borne Encephalitis Virus (TBEV)
Phase 1Not yet recruitingGiuseppe Pantaleo182026-01-012026-01-29
Safety of and Immune Response to a Tick-Borne Encephalitis Vaccine (LGT(TP21)/DEN4) in Healthy Adults
LGT(TP21)/DEN4, Placebo - Tick-Borne Encephalitis
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)282005-07-012008-01-21

Broader conditions

Arbovirus Infections (2)  ·  Brain Diseases (2)  ·  Central Nervous System Diseases (2)  ·  Central Nervous System Infections (2)  ·  Central Nervous System Viral Diseases (2)  ·  Encephalitis (2)  ·  Encephalitis, Arbovirus (2)  ·  Encephalitis, Viral (2)  ·  Flaviviridae Infections (2)  ·  Flavivirus Infections (2)  ·  Infections (2)  ·  Infectious Encephalitis (2)  ·  Nervous System Diseases (2)  ·  Neuroinflammatory Diseases (2)  ·  RNA Virus Infections (2)

Interventions

Infusions, Intravenous (1)

Sponsors

Giuseppe Pantaleo (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)

Countries

Switzerland (1)  ·  United States (1)

Top investigators

Anna Durbin, MD (1)  ·  Peter Wright, MD (1)